Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Bexarotene> ?p ?o. }
Showing items 1 to 93 of
93
with 100 items per page.
- Bexarotene abstract "Bexarotene (brand name: Targretin) is an antineoplastic (anti-cancer) agent indicated by the U.S.Food and Drug Administration (FDA) (in late 1999) and the European Medicines Agency (EMA) (early 2001) for use as a treatment for cutaneous T cell lymphoma (CTCL).".
- Bexarotene atcPrefix "L01".
- Bexarotene atcSuffix "XX25".
- Bexarotene casNumber "153559-49-0".
- Bexarotene chEBI "50859".
- Bexarotene drugbank "DB00307".
- Bexarotene fdaUniiCode "A61RXM4375".
- Bexarotene iupacName "4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid".
- Bexarotene pubchem "82146".
- Bexarotene thumbnail Bexarotene2DACS.svg?width=300.
- Bexarotene wikiPageID "6608143".
- Bexarotene wikiPageRevisionID "603931170".
- Bexarotene atcPrefix "L01".
- Bexarotene atcSuffix "XX25".
- Bexarotene c "24".
- Bexarotene casNumber "153559".
- Bexarotene chebi "50859".
- Bexarotene chembl "1023".
- Bexarotene chemspiderid "74139".
- Bexarotene drugbank "DB00307".
- Bexarotene eliminationHalfLife "25200.0".
- Bexarotene excretion "Parent drug and metabolites are eliminated primarily through the hepatobiliary system. Less than 1% is excreted in the urine unchanged.".
- Bexarotene h "28".
- Bexarotene hasPhotoCollection Bexarotene.
- Bexarotene image "Bexarotene3Dan.gif".
- Bexarotene inchi "1".
- Bexarotene inchikey "NAVMQTYZDKMPEU-UHFFFAOYAX".
- Bexarotene iupacName "4".
- Bexarotene iupharLigand "2807".
- Bexarotene legalAu "S4".
- Bexarotene legalUk "POM".
- Bexarotene legalUs "Rx-only".
- Bexarotene licenceEu "Targretin".
- Bexarotene licenceUs "Bexarotene".
- Bexarotene medlineplus "a608006".
- Bexarotene metabolism "Hepatic".
- Bexarotene molecularWeight "348.478".
- Bexarotene o "2".
- Bexarotene pregnancyUs "X".
- Bexarotene proteinBound ">99%".
- Bexarotene pubchem "82146".
- Bexarotene routesOfAdministration "Oral and topical".
- Bexarotene smiles "O=Cc1cccC=C".
- Bexarotene stdinchi "1".
- Bexarotene stdinchikey "NAVMQTYZDKMPEU-UHFFFAOYSA-N".
- Bexarotene tradename "Targretin".
- Bexarotene unii "A61RXM4375".
- Bexarotene verifiedrevid "477165047".
- Bexarotene watchedfields "changed".
- Bexarotene width "200".
- Bexarotene subject Category:Antineoplastic_drugs.
- Bexarotene subject Category:Benzoic_acids.
- Bexarotene subject Category:Retinoids.
- Bexarotene subject Category:SRI_International.
- Bexarotene subject Category:Tetralins.
- Bexarotene type Abstraction100002137.
- Bexarotene type Acid114607521.
- Bexarotene type BenzoicAcid114775321.
- Bexarotene type BenzoicAcids.
- Bexarotene type CarboxylicAcid114739360.
- Bexarotene type Chemical114806838.
- Bexarotene type Compound114818238.
- Bexarotene type Material114580897.
- Bexarotene type Matter100020827.
- Bexarotene type Part113809207.
- Bexarotene type PhysicalEntity100001930.
- Bexarotene type Relation100031921.
- Bexarotene type Substance100019613.
- Bexarotene type Drug.
- Bexarotene type DrugProduct.
- Bexarotene type FunctionalSubstance.
- Bexarotene comment "Bexarotene (brand name: Targretin) is an antineoplastic (anti-cancer) agent indicated by the U.S.Food and Drug Administration (FDA) (in late 1999) and the European Medicines Agency (EMA) (early 2001) for use as a treatment for cutaneous T cell lymphoma (CTCL).".
- Bexarotene label "Beksaroten".
- Bexarotene label "Bexaroten".
- Bexarotene label "Bexarotene".
- Bexarotene label "Bexarotene".
- Bexarotene label "Bexaroteno".
- Bexarotene label "Bexarotène".
- Bexarotene sameAs Bexaroten.
- Bexarotene sameAs Bexaroteno.
- Bexarotene sameAs Bexarotène.
- Bexarotene sameAs Bexarotene.
- Bexarotene sameAs Beksaroten.
- Bexarotene sameAs m.0gdm16.
- Bexarotene sameAs Q418192.
- Bexarotene sameAs Q418192.
- Bexarotene sameAs bexarotene.
- Bexarotene sameAs DB00307.
- Bexarotene sameAs 82146.
- Bexarotene sameAs Bexarotene.
- Bexarotene wasDerivedFrom Bexarotene?oldid=603931170.
- Bexarotene depiction Bexarotene2DACS.svg.
- Bexarotene isPrimaryTopicOf Bexarotene.